In breast cancer, the defect of lysine demethylase 5C (KDM5C) causes elevation of H3K4me3 on oncogene enhancers, which activates oncogene expression and tumorigenesis (Shen et al., 2016). The gene discussed is KDM5C; the disease is breast cancer.